• Sharebar

So What is the Problem with Noni?

First, yuck! Have you tasted Noni? Yuck! I do believe that Noni juice has value, but I’m not going to drink it!

The real problem however is that Noni was sold as a “be all and end all” for all problems. We should all know, nothing like that can be true. The human body will always need vitamins and minerals (as found in Ultra Vitality Drink) and this product has none.

Noni has been hit heavy by the FDA because of medical claims made.

The Problem with Goji

Unlike Noni juice, Goji juice actually tastes pretty good. I think Goji juice probably is more potent, more protective than Noni.

Like Noni, Goji is sold as a “be all and end all” by many if not most of its Distributors. The web sites for Goji seem more responsible than Noni’s but still its Distributors sell it as that “be all and end all”… they’re blowing smoke.

The problem with Limu

Limu tastes slightly better than Noni. I could drink it if I had to, but I don’t know why I would want to.

Limu has run into the same problem, or worse, than Noni did with the FDA. Again, it was/is sold as a “be all and end all” for all disease. We know what that means.

The problem with XanGo

Depending on your taste buds, you will find this almost as good as Goji or better.

XanGo’s sell is based on xanthones, a class of antioxidants. It’s important to remember no one group of antioxidants does everything or affects all the various systems in the body. Lycopene is great for the prostate and may have some benefit for the heart and the eyes but seems to do little for the kidney or liver. Xanthones may be of great value to some of the body’s organs but not all of them… as seems to be the sell from the company or at least the Distributors.

The real problem may be a lack of the very thing they are selling. Nowhere have they listed the actual amount of xanthones their product contains. There is no standardized processing of the mangosteen being done. Even other sellers of mangosteen products have shown XanGo has little of the antioxidants it touts as being so important.

All of the products above could well be used with benefit but would best be used as a secondary supplement to Ultra Vitality Drink. As the chart clearly shows each of the above drinks has just one or perhaps several of the nutrients found in Symmetry’s Ultra Vitality but none of the essential vitamins, none of the essential minerals and none of the essential fatty acids that are needed for health and for life.

Indeed comparing these products to Ultra Vitality Drink is not a fair comparison at all. It’s like comparing apples to rocking chairs. It would be far more useful and fair to compare these drinks with Mega Juice. Here again, Symmetry wins the comparison hands down though as Mega Juice contains not one class of antioxidants but contains thousands of them, all the antioxidants found in 15 different fruits as well as 15 different vegetables.


Following is some information to support the above statements. There are many, many pages like those that follow available but this gives you an idea of what’s out there. Do please note that I’m talking above “in general” as there are several companies that sell Limu and Noni and not all of them were “hit” by the FDA.

FDA News

Royal Tongan Limu Dietary Supplements Promoted to Treat Various Diseases Destroyed

The Food and Drug Administration (FDA) announced today that NBTY, Inc., of Bohemia, N.Y., has completed its voluntary destruction of approximately 90,000 units of Royal Tongan Limu, a dietary supplement promoted to treat various diseases like cancer, arthritis, and Attention Deficit Disorder (ADD). The destruction of the product, witnessed by FDA Chicago District, occurred October 13 – 17, 2003, at a landfill in Desoto, Ill. It involved approximately $2,700,000 worth of product. Royal Tongan Limu was distributed by Dynamic Essentials, a subsidiary of NBTY located in Lake Mary, Fla. Dynamic Essentials has ceased operation, and no longer promotes or sells the products on its website.

“Getting rid of these bogus products, from a company that was giving false information about health benefits to consumers, underscores the message from FDA to those who would mislead consumers about their health,” said FDA Commissioner Mark B. McClellan, M.D., Ph.D. “We will not tolerate companies that raise false hopes for preventing and treating illnesses, when there are more scientifically proven steps than ever before that consumers can take to improve their health.”

FDA determined the product was being promoted for treatment and mitigation of various diseases after evaluating unsubstantiated therapeutic claims on the company’s website. The firm was initially warned with an FDA “cyber letter” in 2002 informing them that claims on their website caused their products to be in violation of the law.

Among the unsubstantiated therapeutic claims observed on the website included “Limu Moui may make cancer cells pop (self-destruct) and stop cell division.” Other claims include “Limu Moui lubricates joints to make them more flexible and thereby eliminating pain of arthritis, etc.” FDA determined these unapproved drug claims violate the Federal Food, Drug and Cosmetic Act.

Subsequently, in 2003, FDA followed up with an investigation at the firm’s New York and Florida locations that prompted the decision of the firm to voluntarily cease the operations of Dynamic Essentials, Inc., and destroy the product.

Today’s action demonstrates FDA’s continued activities in monitoring the marketplace to ensure that products marketed as dietary supplements are labeled properly and that claims made for these types of products are not false or misleading.

xango orac score

Department of Health and Human Services

Public Health Service
Food and Drug Administration

Seattle District
Pacific Region
22201 23rd Drive SE
Bothell, WA 98021-4421
Telephone: 425-486-8788
FAX: 425-483-4996

August 26, 2004

VIA CERTIFIED MAIL
RETURN RECEIPT REQUESTED

In reply refer to Warning Letter SEA 04-43

Thomas O. Greither, President
Flora, Inc.
P.O. Box 73
Lynden, Washington 98264

WARNING LETTER

Dear Mr. Greither:

This is to advise you that the Food and Drug Administration (FDA) has reviewed your web site at the Internet address http://www.florahealth.com and has determined that the product Pure Hawaiian Noni Juice is promoted for conditions that cause the product to be a drug under section 201(g)(1) of the Federal Food, Drug, and Cosmetic Act (the Act) [21 USC 321(g)(1)]. The therapeutic claims on your web site establish that this product is a drug because it is intended for use in the cure, mitigation, treatment, or prevention of disease. The marketing of this product with these claims violates the Act.

Examples of some of the claims observed on your web site under the heading “What Does Noni Do?” include:

  • “[S]tudies have shown the fruit juice to contain several healing attributes including.. .Scopoletin, which lowers blood pressure and may help in the reduction of arthritic pain, Damnacanthal, a proven inhibitor of ras (pre-cancer) cells.. .”
  • “According to Dr. Isabella Abbott, an expert in botanical sciences, the more common uses of noni include to control diabetes, high blood pressure and cancer.”
  • “Biochemist Dr. Ralph Heinicke has reported noni being used to treat . . . arthritis, gastric ulcers, . . . mental depression, . . . atherosclerosis, and drug addictions.”

And under the heading “Benefits”:

  • “Lowers high blood pressure.. .
  • Relieves arthritis
  • Eliminates gastric ulcers. . .
  • Prevents mental depression
  • Lessens atherosclerosis
  • Helps drug addiction
  • Heals burns
  • Inhibits pre-cancer cell growth
  • Decreases chest infections
  • Improves eye infections. . .
  • Eliminates mouth and throat infections
  • Decreases skin infections”

Your product is misbranded under section 502(f) (1) of the Act [21 USC 352(f)(1)] in that the labeling for this drug fails to bear adequate directions for use. It is a violation of section 301(a) of the Act [21 USC 331(a)] to introduce or deliver for introduction into interstate commerce any drug that is misbranded.

This letter is not intended to be an all-inclusive review of your web site and products your firm may market. It is your responsibility to ensure that all products marketed by your firm are in compliance with the Act and its implementing regulations.

We request that you take prompt action to correct these violations. Failure to promptly correct violations may result in enforcement actions without further notice. These actions include seizure and/or obtaining a court injunction against further marketing of your products.

Please respond in writing within (15) fifteen days from your receipt of this letter. Your response should outline the specific things you are doing to correct these deviations. If you cannot complete all corrections before you respond, we expect you will explain the reason for your delay and state the time at which corrections will be completed. Please send your reply to the Food and Drug Administration, Attention: Lisa M. Althar, Compliance Officer, 22201 23rd Drive SE, Bothell, Washington 98021-4421.

Sincerely,

Celeste M. Corcoran for
Charles M. Breen
District Director

cc: WSDA with disclosure statement